1 Min Read
March 13 (Reuters) - Knight Therapeutics Inc
* Knight Therapeutics announces the Canadian Commercialization of Movantik
* Commercial relaunch of Movantik in Canada Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.